These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26172444)

  • 1. Intermittent bacteremia detected in an asymptomatic apheresis platelet donor with repeat positive culture for Escherichia coli: a case report.
    Ramirez-Arcos S; Alport T; Goldman M
    Transfusion; 2015 Nov; 55(11):2606-8. PubMed ID: 26172444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two cats.
    Bryant BJ; Conry-Cantilena C; Ahlgren A; Felice A; Stroncek DF; Gibble J; Leitman SF
    Transfusion; 2007 Nov; 47(11):1984-9. PubMed ID: 17958526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets.
    Schrezenmeier H; Walther-Wenke G; Müller TH; Weinauer F; Younis A; Holland-Letz T; Geis G; Asmus J; Bauerfeind U; Burkhart J; Deitenbeck R; Förstemann E; Gebauer W; Höchsmann B; Karakassopoulos A; Liebscher UM; Sänger W; Schmidt M; Schunter F; Sireis W; Seifried E
    Transfusion; 2007 Apr; 47(4):644-52. PubMed ID: 17381623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of Streptococcus bovis from apheresis platelets of asymptomatic donor warranted colonoscopy investigation: case report and literature review.
    Lin CY; Tseng SB; Lu PL; Chen TC; Lin WR; Chen YH; Lin KS
    Transfusion; 2011 Sep; 51(9):2023-7. PubMed ID: 21392018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006).
    Eder AF; Kennedy JM; Dy BA; Notari EP; Weiss JW; Fang CT; Wagner S; Dodd RY; Benjamin RJ;
    Transfusion; 2007 Jul; 47(7):1134-42. PubMed ID: 17581147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.
    Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM
    Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of bacteriologic screening in platelet concentrates.
    te Boekhorst PA; Beckers EA; Vos MC; Vermeij H; van Rhenen DJ
    Transfusion; 2005 Apr; 45(4):514-9. PubMed ID: 15819671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of Leclercia adecarboxylata from the blood culture of an asymptomatic platelet donor.
    Davenport P; Land KJ
    Transfusion; 2007 Oct; 47(10):1816-9. PubMed ID: 17880606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation.
    Stevens WT; Bolan CD; Oblitas JM; Stroncek DF; Bennett JE; Leitman SF
    Transfusion; 2006 Apr; 46(4):649-51. PubMed ID: 16584443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk.
    Jenkins C; Ramírez-Arcos S; Goldman M; Devine DV
    Transfusion; 2011 Dec; 51(12):2555-65. PubMed ID: 21615745
    [TBL] [